Literature DB >> 31998956

A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis.

Andrew J Swift1,2, Haiping Lu2,3, Johanna Uthoff3, Pankaj Garg1, Marcella Cogliano1, Jonathan Taylor4, Peter Metherall4, Shuo Zhou3, Christopher S Johns4, Samer Alabed1,4, Robin A Condliffe5, Allan Lawrie1, Jim M Wild1, David G Kiely5.   

Abstract

AIMS: Pulmonary arterial hypertension (PAH) is a progressive condition with high mortality. Quantitative cardiovascular magnetic resonance (CMR) imaging metrics in PAH target individual cardiac structures and have diagnostic and prognostic utility but are challenging to acquire. The primary aim of this study was to develop and test a tensor-based machine learning approach to holistically identify diagnostic features in PAH using CMR, and secondarily, visualize and interpret key discriminative features associated with PAH. METHODS AND
RESULTS: Consecutive treatment naive patients with PAH or no evidence of pulmonary hypertension (PH), undergoing CMR and right heart catheterization within 48 h, were identified from the ASPIRE registry. A tensor-based machine learning approach, multilinear subspace learning, was developed and the diagnostic accuracy of this approach was compared with standard CMR measurements. Two hundred and twenty patients were identified: 150 with PAH and 70 with no PH. The diagnostic accuracy of the approach was high as assessed by area under the curve at receiver operating characteristic analysis (P < 0.001): 0.92 for PAH, slightly higher than standard CMR metrics. Moreover, establishing the diagnosis using the approach was less time-consuming, being achieved within 10 s. Learnt features were visualized in feature maps with correspondence to cardiac phases, confirming known and also identifying potentially new diagnostic features in PAH.
CONCLUSION: A tensor-based machine learning approach has been developed and applied to CMR. High diagnostic accuracy has been shown for PAH diagnosis and new learnt features were visualized with diagnostic potential.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  diagnosis; machine learning; pulmonary arterial hypertension; right ventricle; tensor

Mesh:

Year:  2021        PMID: 31998956      PMCID: PMC7822638          DOI: 10.1093/ehjci/jeaa001

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  32 in total

1.  Right atrial volume and reservoir function are novel independent predictors of clinical worsening in patients with pulmonary hypertension.

Authors:  Takahiro Sato; Ichizo Tsujino; Hiroshi Ohira; Noriko Oyama-Manabe; Yoichi M Ito; Asuka Yamada; Daisuke Ikeda; Taku Watanabe; Masaharu Nishimura
Journal:  J Heart Lung Transplant       Date:  2015-02-07       Impact factor: 10.247

2.  Prognostic value of right ventricular longitudinal strain in patients with pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Hugo G Hulshof; Thijs M H Eijsvogels; Geert Kleinnibbelink; Arie P van Dijk; Keith P George; David L Oxborough; Dick H J Thijssen
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-04-01       Impact factor: 6.875

3.  Pulmonary hypertension: diagnosis and management.

Authors:  David G Kiely; Charlie A Elliot; Ian Sabroe; Robin Condliffe
Journal:  BMJ       Date:  2013-04-16

Review 4.  Deep learning for cardiac computer-aided diagnosis: benefits, issues & solutions.

Authors:  Brian C S Loh; Patrick H H Then
Journal:  Mhealth       Date:  2017-10-19

Review 5.  An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan.

Authors:  Henning Gall; Marius M Hoeper; Manuel J Richter; William Cacheris; Barbara Hinzmann; Eckhard Mayer
Journal:  Eur Respir Rev       Date:  2017-03-29

6.  Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension.

Authors:  C Tji-Joong Gan; Jan-Willem Lankhaar; Nico Westerhof; J Tim Marcus; Annemarie Becker; Jos W R Twisk; Anco Boonstra; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Chest       Date:  2007-11-07       Impact factor: 9.410

7.  Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging.

Authors:  J Katz; J Whang; L M Boxt; R J Barst
Journal:  J Am Coll Cardiol       Date:  1993-05       Impact factor: 24.094

8.  Assessment of right ventricular size and function: echo versus magnetic resonance imaging.

Authors:  Michael D Puchalski; Richard V Williams; Bojana Askovich; L LuAnn Minich; Christopher Mart; Lloyd Y Tani
Journal:  Congenit Heart Dis       Date:  2007 Jan-Feb       Impact factor: 2.007

9.  Right atrial emptying fraction non-invasively predicts mortality in pulmonary hypertension.

Authors:  Konstadina Darsaklis; Matthew E Dickson; William Cornwell; Colby R Ayers; Fernando Torres; Kelly M Chin; Susan Matulevicius
Journal:  Int J Cardiovasc Imaging       Date:  2016-04-13       Impact factor: 2.357

10.  Machine Learning of Three-dimensional Right Ventricular Motion Enables Outcome Prediction in Pulmonary Hypertension: A Cardiac MR Imaging Study.

Authors:  Timothy J W Dawes; Antonio de Marvao; Wenzhe Shi; Tristan Fletcher; Geoffrey M J Watson; John Wharton; Christopher J Rhodes; Luke S G E Howard; J Simon R Gibbs; Daniel Rueckert; Stuart A Cook; Martin R Wilkins; Declan P O'Regan
Journal:  Radiology       Date:  2017-01-16       Impact factor: 11.105

View more
  9 in total

1.  Diagnostic test accuracy of artificial intelligence analysis of cross-sectional imaging in pulmonary hypertension: a systematic literature review.

Authors:  Conor J Hardacre; Joseph A Robertshaw; Shaney L Barratt; Hannah L Adams; Robert V MacKenzie Ross; Graham Re Robinson; Jay Suntharalingam; John D Pauling; Jonathan Carl Luis Rodrigues
Journal:  Br J Radiol       Date:  2021-09-29       Impact factor: 3.039

Review 2.  Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension.

Authors:  Christopher J Rhodes; Andrew J Sweatt; Bradley A Maron
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

3.  Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension.

Authors:  Michal Schäfer; D Dunbar Ivy; Kathleen Nguyen; Katie Boncella; Benjamin S Frank; Gareth J Morgan; Kathleen Miller-Reed; Uyen Truong; Kelley Colvin; Michael E Yeager
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-06-04       Impact factor: 5.125

Review 4.  Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update.

Authors:  Samer Alabed; Pankaj Garg; Christopher S Johns; Faisal Alandejani; Yousef Shahin; Krit Dwivedi; Hamza Zafar; James M Wild; David G Kiely; Andrew J Swift
Journal:  Curr Cardiovasc Imaging Rep       Date:  2020-11-07

Review 5.  From Early Morphometrics to Machine Learning-What Future for Cardiovascular Imaging of the Pulmonary Circulation?

Authors:  Deepa Gopalan; J Simon R Gibbs
Journal:  Diagnostics (Basel)       Date:  2020-11-25

6.  Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension.

Authors:  Catherine E Simpson; Todd M Kolb; Steven Hsu; Stefan L Zimmerman; Celia P Corona-Villalobos; Stephen C Mathai; Rachel L Damico; Paul M Hassoun
Journal:  Pulm Circ       Date:  2022-01-18       Impact factor: 2.886

Review 7.  The Role of Artificial Intelligence in Predicting Outcomes by Cardiovascular Magnetic Resonance: A Comprehensive Systematic Review.

Authors:  Hosamadin Assadi; Samer Alabed; Ahmed Maiter; Mahan Salehi; Rui Li; David P Ripley; Rob J Van der Geest; Yumin Zhong; Liang Zhong; Andrew J Swift; Pankaj Garg
Journal:  Medicina (Kaunas)       Date:  2022-08-12       Impact factor: 2.948

8.  Fully automatic cardiac four chamber and great vessel segmentation on CT pulmonary angiography using deep learning.

Authors:  Michael J Sharkey; Jonathan C Taylor; Samer Alabed; Krit Dwivedi; Kavitasagary Karunasaagarar; Christopher S Johns; Smitha Rajaram; Pankaj Garg; Dheyaa Alkhanfar; Peter Metherall; Declan P O'Regan; Rob J van der Geest; Robin Condliffe; David G Kiely; Michail Mamalakis; Andrew J Swift
Journal:  Front Cardiovasc Med       Date:  2022-09-26

9.  Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension.

Authors:  Anna Hemnes; Alexander M K Rothman; Andrew J Swift; Lawrence S Zisman
Journal:  Pulm Circ       Date:  2020-11-18       Impact factor: 2.886

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.